5-FLUOROURACIL (5-FU) PRESENTING AS A STEMI

被引：0
|
作者：
Okor, Ivana [1 ]
Ghosh, Priyanka [1 ]
Bhattarai, Shraddha [1 ]
Sattur, Sudhakar [1 ]
机构：
[1] Guthrie Robert Packer, Sayre, PA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1555-115
引用
收藏
页码：3439 / 3439
页数：1
相关论文
共 50 条
  • [31] TREATMENT OF KERATOACANTHOMAS BY LOCAL APPLICATIONS OF 5-FLUOROURACIL (5-FU) OINTMENT
    GRUPPER, C
    DERMATOLOGICA, 1970, 140 : 127 - &
  • [32] ORAL 5-FLUOROURACIL (5-FU) AS AN ADJUVANT TO SURGERY IN CARCINOMA OF COLON
    HARVEY, H
    BADDER, E
    DEMUTH, W
    NAHRWOLD, D
    PATTERSON, L
    RICCI, J
    SHAVER, W
    WHITE, D
    LIPTON, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 314 - 314
  • [33] EFFECTS OF 5-FLUOROURACIL (5-FU) OINTMENT IN TREATMENT OF NEOPLASTIC DERMATOSES
    KLEIN, E
    STOLL, HL
    MILLER, E
    MILGROM, H
    HELM, F
    BURGESS, G
    DERMATOLOGICA, 1970, 140 : 21 - +
  • [34] 5-FLUOROURACIL (5-FU) IN PRIMARY TRABECULECTOMY - A PROSPECTIVE, RANDOMIZED STUDY
    GOLDENFELD, M
    WONG, P
    RUDERMAN, J
    ROSENBERG, L
    KRUPIN, T
    GEISER, D
    LIEBMANN, J
    RITCH, R
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1993, 34 (04) : 815 - 815
  • [35] Continuous infusion of 5-fluorouracil (5-FU) in neuroendocrine tumours (NET)
    Ducreux, M
    Baudin, E
    Thabut, D
    Rougier, P
    Tigaud, JM
    Elias, D
    Boige, V
    Schlumberger, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S213 - S213
  • [36] CAN NMR CONTRIBUTE TO THE RADIOPHARMACOKINETICS OF 5-FLUOROURACIL (5-FU) IN MAN
    WOLF, W
    GRIFFITHS, JR
    SILVER, M
    BRUCKNER, H
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (05) : 737 - 737
  • [37] A unique presentation of 5-fluorouracil (5-FU) induced cerebral encephalopathy
    Naik, Shailendra S.
    Vanidassane, Ilavarasi
    Dhamija, Ekta
    Sharma, Atul
    INDIAN JOURNAL OF RADIOLOGY AND IMAGING, 2020, 30 (02): : 214 - 217
  • [38] BIOCHEMICAL MODULATION OF 5-FLUOROURACIL (5-FU) ACTIVITY BY URIDINE (URD)
    VANGROENINGEN, CJ
    LEYVA, A
    PETERS, GJ
    LAURENSSE, E
    PINEDO, HM
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 132 - 132
  • [39] 5-FLUOROURACIL (5-FU) PHARMACOKINETICS FOLLOWING VARIOUS ROUTES OF ADMINISTRATION
    SADEE, W
    FINN, C
    SCHWANDT, HJ
    YALE, L
    LEE, YT
    BATEMAN, JR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 187 - 187
  • [40] 5-fluorouracil (5-FU) plasma exposure and outcome in patients receiving a TPF (taxotere, cisplatin, 5-FU) chemotherapy
    Legand, C.
    Blasco, H.
    Benz, I.
    Chapet, C.
    Le Guellec, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 25 - 25
12345